Bio-Techne
TECH
$83.50
Share price
-0.77%
Change (1 day)
2.98%
Change (1 year)
Categories
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.
Bio-Techne (TECH) - P/B ratio
P/B ratio as of May 2024 : 6.70
According to Bio-Techne's latest financial reports the company has a price-to-book ratio of 6.70.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Bio-Techne - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 6.21 | -12.72% |
| 2022-12-31 | 7.12 | -40.37% |
| 2021-12-31 | 11.9 | 49.09% |
| 2020-12-31 | 8.01 | 26.12% |
| 2019-12-31 | 6.35 | 27.49% |
| 2018-12-31 | 4.98 | 2.4% |
| 2017-12-31 | 4.86 | 12.9% |
| 2016-12-31 | 4.31 | 10.21% |
| 2015-12-31 | 3.91 | -6.45% |
| 2014-12-31 | 4.18 | -10.47% |
| 2013-12-31 | 4.67 | 28.75% |
| 2012-12-31 | 3.63 | -14.24% |
| 2011-12-31 | 4.23 | -6.02% |
| 2010-12-31 | 4.50 | -13.98% |
| 2009-12-31 | 5.23 | -9.1% |
| 2008-12-31 | 5.75 | 4.03% |
| 2007-12-31 | 5.53 | -2.42% |
| 2006-12-31 | 5.67 | -26.33% |
| 2005-12-31 | 7.69 | 59.03% |
| 2004-12-31 | 4.84 | -17.16% |
| 2003-12-31 | 5.84 | 10.83% |
| 2002-12-31 | 5.27 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 4.88 | -27.16% | 🇺🇸 USA |
 Becton Dickinson BDX | 2.73 | -59.27% | 🇺🇸 USA |
 General Electric GE | 5.75 | -14.15% | 🇺🇸 USA |
 Danaher DHR | 3.65 | -45.52% | 🇺🇸 USA |
 Qiagen QGEN | 2.82 | -57.91% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | 0.7962 | -88.12% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | 0.9502 | -85.82% | 🇺🇸 USA |